Back to Search
Start Over
Efficacy and safety of novel carbapenem-β-lactamase inhibitor combinations: imipenem-cilastatin/relebactam results from randomized controlled trials.
- Source :
- Frontiers in Medicine; 2024, p1-10, 10p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 2296858X
- Database :
- Complementary Index
- Journal :
- Frontiers in Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 174705551
- Full Text :
- https://doi.org/10.3389/fmed.2023.1304369